Can the Results of the European Randomized Study of Screening for Prostate Cancer Be Decontaminated?

被引:1
|
作者
Metcalfe, Chris [1 ]
机构
[1] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England
关键词
D O I
10.1016/j.eururo.2013.08.058
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:337 / 338
页数:2
相关论文
共 50 条
  • [41] Updated results from the European Randomized Study of Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: are Asian countries encouraged to promote PSA screening?
    Sugimoto, Mikio
    Kakehi, Yoshiyuki
    ASIAN JOURNAL OF ANDROLOGY, 2012, 14 (04) : 522 - 524
  • [42] Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised Screening: Long-term Results from the European Randomized Study of Screening for Prostate Cancer Rotterdam
    de Vos, Ivo I.
    Remmers, Sebastiaan
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2024, 85 (01) : 74 - 81
  • [43] PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer
    Otto, S. J.
    Moss, S. M.
    Maattanen, L.
    Roobol, M.
    Zappa, M.
    Nelen, V.
    Kwiatkowski, M.
    Villers, A.
    Hugosson, J.
    Sanchez, A. Berenguer
    de Koning, H. J.
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (17) : 3053 - 3060
  • [44] Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)
    Schroder, Fritz H.
    Hugosson, Jonas
    Carlsson, Sigrid
    Tammela, Teuvo
    Maattanen, Liisa
    Auvinen, Anssi
    Kwiatkowski, Maciej
    Recker, Franz
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2012, 62 (05) : 745 - 752
  • [45] A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
    Andrew J Vickers
    Angel M Cronin
    Gunnar Aus
    Carl-Gustav Pihl
    Charlotte Becker
    Kim Pettersson
    Peter T Scardino
    Jonas Hugosson
    Hans Lilja
    BMC Medicine, 6
  • [46] A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: Data from the European randomized study of prostate cancer screening (ERSPC) in Goteborg, Sweden
    Vickers, Andrew J.
    Cronin, Angel M.
    Aus, Gunnar
    Pihl, Carl G.
    Becker, Charlotte
    Pettersson, Kim
    Scardino, Peter T.
    Hugosson, Jonas
    Lilja, Hans
    JOURNAL OF UROLOGY, 2008, 179 (04): : 719 - 719
  • [47] Prostate-specific antigen change in the European Randomized Study of screening for prostate cancer, section Rotterdam
    Raaijmakers, R
    Wildhagen, MF
    Ito, K
    Pàez, A
    De Vries, SH
    Roobol, MJ
    Schröder, FH
    UROLOGY, 2004, 63 (02) : 316 - 320
  • [48] Intermediate endpoints of prostate cancers detected in the European Randomized Study of Screening for Prostate Cancer, Section Rotterdam
    Van der Cruijsen-Koeter, I. W.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 274 - 274
  • [49] The use of European Randomized study of Screening for Prostate Cancer calculator as a diagnostic tool for prostate biopsy indication
    Breza, J.
    Subin, F.
    Bernadic, M.
    Tomas, M.
    Pindak, D.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2019, 120 (05): : 331 - 335
  • [50] Predictors for biopsy outcome in the European randomized study of screening for prostate cancer (Rotterdam region)
    Kranse, R
    Beemsterboer, P
    Rietbergen, J
    Habbema, D
    Hugosson, J
    Schröder, FH
    PROSTATE, 1999, 39 (04): : 316 - 322